Tempus Wealth Planning, LLC Alvotech Transaction History
Tempus Wealth Planning, LLC
- $297 Million
- Q4 2024
A detailed history of Tempus Wealth Planning, LLC transactions in Alvotech stock. As of the latest transaction made, Tempus Wealth Planning, LLC holds 23,467 shares of ALVO stock, worth $302,958. This represents 0.1% of its overall portfolio holdings.
Number of Shares
23,467Holding current value
$302,958% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding ALVO
# of Institutions
37Shares Held
15.6MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.17MShares$41 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$34.9 Million28.94% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca2.53MShares$32.7 Million0.64% of portfolio
-
Morgan Stanley New York, NY1.74MShares$22.5 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$17 Million6.38% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $3.21B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...